These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19469654)

  • 1. Differential gene expression of bone marrow CD34+ cells in early and advanced myelodysplastic syndrome.
    Vasikova A; Budinska E; Belickova M; Cermak J; Bruchova H
    Neoplasma; 2009; 56(4):335-42. PubMed ID: 19469654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow.
    Hofmann WK; de Vos S; Komor M; Hoelzer D; Wachsman W; Koeffler HP
    Blood; 2002 Nov; 100(10):3553-60. PubMed ID: 12411319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
    Chaudhary AK; Chaudhary S; Ghosh K; Shanmukaiah C; Nadkarni AH
    Asian Pac J Cancer Prev; 2016; 17(3):1519-29. PubMed ID: 27039800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
    Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
    Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal WT1 expression in the CD34-negative compartment in myelodysplastic bone marrow.
    Van Dijk JP; Knops GH; Van De Locht LT; Menke AL; Jansen JH; Mensink EJ; Raymakers RA; De Witte T
    Br J Haematol; 2002 Sep; 118(4):1027-33. PubMed ID: 12199781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression.
    Sridhar K; Ross DT; Tibshirani R; Butte AJ; Greenberg PL
    Blood; 2009 Nov; 114(23):4847-58. PubMed ID: 19801443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Rap1GAP in human myeloid disease following microarray selection.
    Qi X; Chen Z; Qian J; Cen J; Gu M
    Genet Mol Res; 2008 Apr; 7(2):379-87. PubMed ID: 18551404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome.
    Sternberg A; Killick S; Littlewood T; Hatton C; Peniket A; Seidl T; Soneji S; Leach J; Bowen D; Chapman C; Standen G; Massey E; Robinson L; Vadher B; Kaczmarski R; Janmohammed R; Clipsham K; Carr A; Vyas P
    Blood; 2005 Nov; 106(9):2982-91. PubMed ID: 16076868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes.
    Li X; Marcondes AM; Gooley TA; Deeg HJ
    Blood; 2010 Sep; 116(13):2304-14. PubMed ID: 20562331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes.
    Sawanobori M; Yamaguchi S; Hasegawa M; Inoue M; Suzuki K; Kamiyama R; Hirokawa K; Kitagawa M
    Leuk Res; 2003 Jul; 27(7):583-91. PubMed ID: 12681357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression in CD34(+) cells from normal bone marrow and leukemic origins.
    Gu J; Zhang QH; Huang QH; Ren SX; Wu XY; Ye M; Huang CH; Fu G; Zhou J; Niu C; Han ZG; Chen SJ; Chen Z
    Hematol J; 2000; 1(3):206-17. PubMed ID: 11920191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of TET2 in CD3⁺ and CD34⁺ cells of myelodysplastic syndromes and enhances CD34⁺ cells proliferation.
    Zhang W; Shao Z; Fu R; Wang H; Li L; Liu H
    Int J Clin Exp Pathol; 2015; 8(9):10840-6. PubMed ID: 26617797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine.
    Giachelia M; D'Alò F; Fabiani E; Saulnier N; Di Ruscio A; Guidi F; Hohaus S; Voso MT; Leone G
    Leuk Res; 2011 Apr; 35(4):465-71. PubMed ID: 20869114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
    Pellagatti A; Cazzola M; Giagounidis AA; Malcovati L; Porta MG; Killick S; Campbell LJ; Wang L; Langford CF; Fidler C; Oscier D; Aul C; Wainscoat JS; Boultwood J
    Blood; 2006 Jul; 108(1):337-45. PubMed ID: 16527891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy.
    Radujkovic A; Dietrich S; Andrulis M; Benner A; Longerich T; Pellagatti A; Nanda K; Giese T; Germing U; Baldus S; Boultwood J; Ho AD; Dreger P; Luft T
    Int J Cancer; 2016 Sep; 139(6):1402-13. PubMed ID: 27170453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndrome.
    Prall WC; Czibere A; Grall F; Spentzos D; Steidl U; Giagounidis AAN; Kuendgen A; Otu H; Rong A; Libermann TA; Germing U; Gattermann N; Haas R; Aivado M
    Int J Hematol; 2009 Mar; 89(2):173-187. PubMed ID: 19152102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
    Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
    Pellagatti A; Marafioti T; Paterson JC; Malcovati L; Della Porta MG; Jädersten M; Pushkaran B; George TI; Arber DA; Killick S; Giagounidis A; Hellström-Lindberg E; Cazzola M; Wainscoat JS; Boultwood J
    Br J Haematol; 2009 Jun; 146(1):86-90. PubMed ID: 19438482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes.
    Vasilatou D; Papageorgiou SG; Kontsioti F; Kontos CK; Tsiotra P; Mpakou V; Pavlou MA; Economopoulou C; Dimitriadis G; Dervenoulas J; Pappa V
    Leuk Res; 2013 Mar; 37(3):251-8. PubMed ID: 23246221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome.
    Qian J; Chen Z; Wang W; Cen J; Xue Y
    Oncol Rep; 2005 Nov; 14(5):1189-97. PubMed ID: 16211284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.